Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 36 results for "zydus cadila"

Zydus Cadila gets USFDA's final nod for antihistamine drug

Zydus Cadila gets USFDA nod to market alcohol abstinence drug

Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for maintenance of abstinence from alcohol in the US market. "Zydus Cadila has received the final approval from the United ... Business Standard, 17 hours ago
Zydus Cadila gets USFDA nod for antihistamine drug Business Standard, 4 days ago

21 images for zydus cadila

DNA, 4 days ago
Money Control, 2 weeks ago
Money Control, 2 months ago
Money Control, 3 months ago
Business Standard India, 4 months ago
Money Control, 4 months ago
Franchise India, 4 months ago, 4 months ago
DealStreetAsia, 4 months ago
Business Standard India, 6 months ago
Money Control

Zydus Cadila receives final approval for Cyproheptadine Hydrochloride Tablets USP

 Business Standard4 days ago Zydus Cadila receives US FDA approval for anti-inflammatory drug budesonide  Business Standard3 weeks ago Zydus receives final approval from USFDA for Budesonide capsules  Money Control3 weeks ago Zydus Cadila receives USFDA's nod for Olmesartan Medoxomil tablets  Myiris1 month ago

75% of EPI vaccines are produced in India: Pankaj Patel, Zydus Cadila

On this special episode of The India Road Show, CNBC-TV18's Sanjay Suri speaks to a panel of corporate leaders experts to talk about how their sectors have done in the past three years of the Modi Government. Watch accompanying video for more...
 Money Control1 week ago
Money Control

US court rules in favour of drug firm Zydus Cadila in patent case

The Court of Appeals' decision is a major step toward Zydus providing a generic version of Lialda
 Business Standard2 weeks ago US court rules in favour of Zydus Cadila in patent case  DNA2 weeks ago

Sun Pharma, Cadila Healthcare recall products from US market

While Sun Pharmaceutical Industries Inc is recalling 83,188 single dose vials of Testosterone Cypionate injection, Zydus Pharmaceuticals USA Inc is recalling 9,561 bottles Atenolol tablets.
 DNA1 month ago
Money Control

Cadila inks pact with Supernus Pharma to settle patent issue

Cadila Healthcare, along with subsidiary Zydus Pharmaceuticals (USA) Inc, have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation related to Trokendi XR (topiramate) extended-release capsules, Cadila ...
 Money Control2 months ago Need to keep pace with industry on tech upgradation: Sun Pharma  Money Control2 months ago
Money Control

Zydus subsidiary receives USFDA nod to market Tamiflu drug

Drug firm Zydus Cadila's US subsidiary has received approval from the US health regulator to market oseltamivir phosphate capsules used for the treatment of Tamiflu.
 DNA2 months ago

Cadila gets stakeholders' nod for scheme of arrangement

Drug firm Cadila Healthcare has received overwhelming approval from stakeholders for scheme of arrangement between the company and Zydus Healthcare Ltd. Almost 100 per cent shareholders have approved "the scheme of arrangement between Cadila Healthcare Ltd ...
 Business Standard1 month ago

Global Stock Markets End on a Positive Note with Emerging Markets leading Gains

Posted by Equitymaster Global financial markets ended the week on a positive note with a boost from emerging markets. The share markets of Brazil, Hong Kong and Japan were up 3.8%, 2.8% and 2.2% respectively. However, share markets in United States and France ...
 Equitymaster.com2 weeks ago Sensex Pares Gains; Power Stocks Drag  Equitymaster.com2 weeks ago Sensex Opens Lower; Realty Stocks Drag  Equitymaster.com4 weeks ago Sensex Remains Range Bound; Metal Stocks Drag  Equitymaster.com2 months ago

Sensex, Nifty caught in tight band amid stock specific activity

The market is quite sluggish today with investors largely treading cautiously, looking ahead to the US President Donald Trump's speech on Tuesday, which is likely to spell out some elements of his plans to cut taxes. Activity is quite stock specific with ...
 Sify2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less